VVT Med Inc.

About VVT Med Inc.

VVT Medical (TSXv:VVTM) is dedicated to advancing vein care through minimally invasive, office-based treatments that reduce procedural complexity, recovery time, and adverse effects. Their proprietary products deliver precise, controlled therapy for patients with varying venous pathologies.

Products & Services

ScleroSafe™:A catheter-based solution designed to treat a wide range of vein diameters using mechanochemical technology that combines controlled sclerosant injection with simultaneous vessel collapse and blood aspiration, ensuring effective vein closure with minimal side effects.

V-Block™:A synergistic catheter-based solution complementing ScleroSafe™, designed to address various vein sizes with the same mechanochemical technology for effective treatment and minimal side effects.

Specialties

Venous therapy Minimally invasive treatments Mechanochemical technology Vein care solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 3000000 MR: - FA: $3,000,000 FAN: 3000000	D: 2026-03-18 FD: 2026-03-18	-

Private Placement Latest

2026-03-18

$3.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Erez Tetro

CEO & Director

D

Dor Sneh

CFO

L

Liron Tayeb

VP R&D

P

Pazit Waks

VP QA&RA

O

Orly Efraty

VP Global Marketing

E

Eyal Alon

VP Global Sales

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

VVT Med Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised